We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

5 hedge funds and large institutions have $8.22M invested in DermTech, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $7.95M → $8.22M (+$268K)

0% more funds holding

Funds holding: 55 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
MSU
Mizuho Securities USA
New York
+$215K
2
CI
Cowen Inc
New York
+$126K
3
CL
CSS LLC
Illinois
+$92.5K

Top Sellers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
-$155K
2
UBS Group
UBS Group
Switzerland
-$77.1K
Name Holding Trade Value Shares
Change
Change in
Stake
CI
1
Cowen Inc
New York
$7.9M +$126K +6,131 +2%
MSU
2
Mizuho Securities USA
New York
$218K +$215K +10,472 New
CL
3
CSS LLC
Illinois
$94K +$92.5K +4,511 New
TRCT
4
Tower Research Capital (TRC)
New York
$6K
UBS Group
5
UBS Group
Switzerland
$2K -$77.1K -3,759 -98%
KC
6
Kepos Capital
New York
-$155K -7,500 Closed

DMTK Hedge Fund Activity: Q2 2019 in Review

5 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2019, worth a combined $8.22M — up 3.4% from $7.95M a quarter earlier.

Fund positioning in DMTK was balanced in Q2 2019: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Mizuho Securities USA, opening a new position worth an estimated $215K. The largest seller was Kepos Capital, exiting entirely with an estimated $155K sold.

  • 5 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $8.22M of DermTech, Inc. Common Stock stock for Q2 2019, up 3.4% quarter-over-quarter.
  • 2 funds opened new DermTech, Inc. Common Stock positions in Q2 2019 and 2 closed out, a net change of 0 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q2 2019 was Mizuho Securities USA, an estimated $215K added.
  • The largest DermTech, Inc. Common Stock seller in Q2 2019 was Kepos Capital, an estimated $155K sold.

Based on aggregated 13F filings for Q2 2019.